Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 856 results for "daiichi sankyo company"

BSE gains over 100 points as markets regain some ground

Sun Pharma: long-term portfolio therapy

Sun Pharma's stock lost about 9 per cent of its value the past week after Japanese drug-maker Daiichi Sankyo sold its 9 per cent stake in the company. Given the robust long-term prospects of Sun Pharma, investors with a three/five-year investment ... Hindu Business Line, 1 day ago

25 images for daiichi sankyo company

Deccan Chronicle, 4 days ago
IBN Live, 6 days ago
India Infoline, 22 hours ago
The Fiscal Times, 5 days ago
Business Today India, 4 days ago
Sify, 5 days ago, 4 days ago
Sify, 1 week ago
Financial Express, 1 day ago
Daiichi Pharmaceutical, 2 weeks ago
Nikkei Asian Review

Daiichi Sankyo's India exit, a Credit Positive

Daiichi Sankyo Company Limited (DSL, A1 stable) sold its entire 9% stake in India-based Sun Pharmaceutical Industries Ltd (SPI, unrated) for around $3.2 billion of gross proceeds, based on the market price of shares on that day. Despite exiting its ...
 India Infoline22 hours ago DAIICHI SANKYO : India exit, a Credit Positive  4 Traders17 hours ago Daiichi Sankyo divests from India's Sun Pharma  Nikkei Asian Review6 days ago
Money Today

Shanghvi did not buy Daiichi Sankyo's shares: Sun Pharma

New Delhi: Drug major Sun Pharmaceutical on Wednesday said its promoter and Managing Director Dilip Shanghvi did not buy shares of the company sold by the Japanese drugmaker Daiichi Sankyo. "...Dilip Shanghvi has neither purchased nor agreed to ...
 Topnews.in5 days ago Shanghvi did not buy Daiichi stock: Sun Pharma  Money Today5 days ago Shanghvi did not buy Daiichi shares, clarifies Sun Pharma  Economic Times5 days ago Founder Dilip Shanghvi did not buy Daiichi stake, Sun Pharmaceutical says  Fierce CRO4 days ago

Sale size made Daiichi Sankyo opt for bulk deal

Japanese pharma major Daiichi Sankyo exited Sun Pharma for around $3 billion (nearly Rs 20,000 crore) in what was considered as the biggest ever bulk deal in the history of the Indian markets. So what exactly does a bulk deal constitute, and why did Daiichi ...
 Deccan Herald5 days ago Daiichi Sankyo's misery ends, block deal gives co the final coup de grce  Firstpost.com5 days ago

Daiichi deal blows 11% off Sun Pharma stock price

Sun Pharma shares plunged nearly 11 per cent after Japan’s Daiichi Sankyo sold its entire holding in the Indian drug major for an estimated Rs 20,420 crore through open market transactions. A combined 276.63 million shares representing 11.5 per cent of ...
 The Financial Chronicle6 days ago Sun Pharma share price dives as Daiichi Sankyo says sayonara  Hindu Business Line6 days ago

Stocks to watch in trade today

Sun Pharma: As part of its strategy to exit India, Japanese pharmaceuticals company Daiichi Sankyo will sell its 8.9% in Sun Pharmaceuticals, worth Rs 22,610 crore, in block deals in the stock market on Tuesday. PFC: The state-owned Power Finance ...
 Business Standard India6 days ago
Money Today

Daiichi Sankyo Completes Sale of Sun Pharma Shares

Tokyo, Japan (April, 21, 2015) - Following the announcement yesterday that Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) decided to sell the entire or part of its holdings of Sun Pharmaceutical Industries Ltd. (hereafter, Sun Pharma) ...
 FirstWord Pharma6 days ago Sun Pharma slumps on Daiichi's share sale buzz  Arihant Capital6 days ago Sun Pharma shares tank on Daiichi sale  Money Today6 days ago DAIICHI SANKYO : Completes Sale of Sun Pharma Shares  4 Traders5 days ago

A generic misadventure

Email this Print Daiichi Sankyo has emerged from a long spell of infirmity in India with its financial faculties just about intact. The Japanese group's 2008 purchase of a stake in local drugmaker Ranbaxy was once a fable about overseas expansion ...
 Smart Investor5 days ago Daiichi Sankyo scrubs out Indian M&A nightmare  Hindu Business Line6 days ago

Indian Stocks Retreat as Sun Pharma Slumps on Daiichi Stake Sale

Indian stocks dropped for a fifth day, with the benchmark index at three-week low, as health-care companies and software exporters declined amid concern that corporate earnings may lag behind estimates. Sun Pharmaceutical Industries Ltd. headed ...
 Bloomberg6 days ago Sun exit — Daiichi shadow on India  Hindu Business Line6 days ago Daiichi's exit from Sun and its signals of caution  Hindu Business Line6 days ago

Daiichi Sankyo Sells Full Sun Stake Worth $3.6 Billion

Japanese drug major Daiichi Sankyo has divested its entire in Sun Pharmaceutical Industries Ltd. A company statement said it has completed the sale of 214,969,058 shares through the stock exchanges on ...
 Businessworld India6 days ago Daiichi Sankyo Begins Sale of $3.6 Billion Stake in Sun Pharma  La Repubblica1 week ago Daiichi to Sell at Least Part of $3.6 Billion Sun Stake  Bloomberg1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - daiichi sankyo company
Get updated on latest news & your favorite topics right in your inbox!
More     Less